Skip to content

Clinical trials

Bone Neoplasms trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Neoplasms Country / region: Russia Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20081
20111
20121
20141
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated3
Unknown status3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blokhin's Russian Cancer Research Center2
Hoffmann-La Roche2
Amgen1
InSightec1
Infinity Pharmaceuticals, Inc.1
N.N. Petrov National Medical Research Center of Oncology1
NextGen Company Limited1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Neoplasms10
Neoplasm Metastasis4
Neoplasms3
Multiple Myeloma2
Osteosarcoma2
Pain2
Alveolar Bone Loss1
Blood Protein Disorders1
Bone Diseases1
Bone Marrow Diseases1

Trials

Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.